Clearline Capital’s Athenahealth, Inc. ATHN Stock Holding History

Clearline Capital’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,697	Closed	-$588K	–	62
2018 Q2	$588K	Buy	+3,697	New	+$548K	0.38%	44

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Clearline Capital's ATHN Position: Q3 2018 in Review

Clearline Capital sold out of Athenahealth, Inc. (ATHN) in Q3 2018, closing a stake of 3,697 shares — an estimated $588K sold.

Clearline Capital first reported a position in ATHN in Q2 2018 and held it in 1 quarter. The position peaked at $588K in Q2 2018. 276 funds tracked by Wall St. Rank hold ATHN as of Q3 2018.

Clearline Capital reported no remaining Athenahealth, Inc. position as of Q3 2018 after selling out during the quarter.
Clearline Capital sold 3,697 Athenahealth, Inc. shares in Q3 2018, an estimated $588K.
Clearline Capital first reported a position in Athenahealth, Inc. in Q2 2018 and held it in 1 quarter.
Clearline Capital's Athenahealth, Inc. position peaked at $588K in Q2 2018.
276 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q3 2018.

Based on Clearline Capital's 13F filing for Q3 2018, filed 14 Nov 2018.